Arrowstreet Capital, Limited Partnership Mei Pharma, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.6 - $3.65 $589,407 - $827,436	-226,695 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$2.73 - $4.5 $245,413 - $404,527	89,895 Added 65.71%	226,695 $778,000
Q4 2020 Feb 12, 2021	BUY	$2.6 - $3.32 $311,740 - $398,068	119,900 Added 709.47%	136,800 $361,000
Q3 2020 Nov 12, 2020	BUY	$2.46 - $4.27 $41,574 - $72,163	16,900 New	16,900 $53,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $366M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.